During the past decade, City Cardiology Associates conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "City Cardiology Associates" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "City Cardiology Associates" are "Acute Coronary Syndrome" (1 trials), "Heart Failure" (1 trials), "Heart Failure Low Output" (1 trials), "Optim Lead Insulation Related Adverse Events" (1 trials) and "Sudden Cardiac Arrest" (1 trials). Many other conditions were trialed in "City Cardiology Associates" in a lesser frequency.

Most popular intervention types in "City Cardiology Associates" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (1 trials), "Placebo" (1 trials) and "Wearable Cardioverter Defibrillator" (1 trials). Other intervention names were less common.

The vast majority of trials in "City Cardiology Associates" are 3 trials for "All" genders.

Currently, there are NaN active trials in "City Cardiology Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in City Cardiology Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in City Cardiology Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".